-
TMO's New Share Buyback Program - Analyst Blog
Friday, September 10, 2010 - 1:06pm | 531Recently, Thermo Fisher Scientific (TMO), one of the leading scientific instruments makers, announced a $750 million share repurchase program, which will remain effective until September 8, 2011. Earlier, the company had announced another $750 million share buyback program, of which $188 million...
-
Downside Purchased on Illumina (ILMN)
Friday, September 10, 2010 - 12:19pm | 185Shares of Illumina, Inc. (NASDAQ: ILMN) are lower on the session by 1.60%, currently trading at $44.29. The stock has been moving largely higher over the past five months, though has come under selling pressure as of late. Options traders are bracing for further declines today. The September $44....
-
Good News for Luminex MAGPIX - Analyst Blog
Thursday, September 9, 2010 - 11:39am | 481Luminex Corporation (LMNX), a developer of biological testing technologies, has reported encouraging results for its new MAGPIX analytical instrument (launched in July 2010). Results from a comparative study conducted at the Natural and Medical Science Institute (NMI) of the University of Tubingen...
-
Thermo Fisher Approves $750M Buyback
Thursday, September 9, 2010 - 10:41am | 50Thermo Fisher Scientific (NYSE: TMO), the maker of scientific instruments, said its board approved a $750 million share repurchase plan. The plan will last through September 2011. The Massachusetts-based company still has $188 million remaining on a previous buyback plan that will last through...
-
Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest ROE (GILD, TLCR, TECH, AMGN)
Thursday, September 9, 2010 - 7:13am | 132Below are the top biotechnology stocks on the NASDAQ in terms of return on equity. The trailing-twelve-month return on equity at Gilead Sciences Inc (NASDAQ: GILD) is 51.77%. GILD’s operating margin for the same period is 53.40%. The trailing-twelve-month return on equity at Talecris...
-
BioDelivery Sciences to Present at Rodman & Renshaw, Baird, and Stifel Nicolaus Investor Conferences
Wednesday, September 8, 2010 - 7:04am | 149BioDelivery Sciences International, Inc. (NASDAQ: BDSI) today announced its participation at three upcoming investor conferences. Dr. Mark A. Sirgo, President and Chief Executive Officer, will present at each conference where he will focus on BDSI’s product pipeline, including BEMA Buprenorphine...
-
Varian downgraded to Neutral from Buy at UBS
Wednesday, September 8, 2010 - 6:58am | 25UBS downgraded Varian, Inc. (NASDAQ: VARI) following checks that indicate a lower industry outlook on semi capex.
-
Red Signal for AstraZeneca Drug - Analyst Blog
Tuesday, September 7, 2010 - 11:42am | 447AstraZeneca plc (AZN) recently announced that its biologics unit, MedImmune, received yet another Complete Response Letter (CRL) from the US Food and Drug Administration (FDA) for motavizumab, which is being studied for the prevention of serious respiratory syncytial virus (RSV) disease in high-...
-
Benzinga’s Top Pre-Market NASDAQ Gainers (TTWO, FNSR, ULTA, QGEN)
Friday, September 3, 2010 - 8:44am | 139Take-Two Interactive Software Inc (NASDAQ: TTWO) rose 12.99% to $10 in the pre-market session. TTWO had reported an unexpected FQ3 profit. Finisar Corporation (NASDAQ: FNSR) added 11.61% to $15.19 in pre-market trading. FNSR had posted upbeat results for its fiscal first quarter. Ulta Salon,...
-
MDS to Release Q3 2010 Financial Results
Friday, September 3, 2010 - 8:08am | 73MDS Inc. (NYSE: MDZ) today announced that the Company will report its third quarter 2010 financial results after market hours on September 14, 2010. Third Quarter 2010 Conference Call The Company will also host an analyst conference call with Steve West, Chief Executive Officer and Peter Dans,...
-
Company News for September 1, 2010 - Corporate Summary
Wednesday, September 1, 2010 - 1:03pm | 726• Joy Global (NASDAQ: JOYG) reported fiscal third quarter earnings ten cents higher than estimated at $1.13, on a 11.1% revenue decline to $850 million, off projections of $877 million • PerkinElmer (NYSE: PKI) agreed to sell its illumination and detection solutions business to a private equity...
-
Zacks #5 Rank Additions for Wednesday - Tale of the Tape
Wednesday, September 1, 2010 - 8:33am | 345Here are 5 stocks added to the Zacks #5 Rank ("strong sell") List today: American Eagle Outfitters (AEO) BJ's Wholesale Club, Inc (BJ) CommScope, Inc (CTV) Covance Inc (CVD) Danaos Corp (DAC) View the entire Zacks #5 Rank List. AMER EAGLE OUTF (AEO): Free Stock Analysis Report BJ'S...
-
Stocks To Watch For September 1 (HNZ, PKI, PSS, HPQ, SAI)
Wednesday, September 1, 2010 - 5:04am | 251Some of the stocks that may grab the investor focus today are: Wall Street expects HJ Heinz Company (NYSE: HNZ) to report its earnings at $0.73 per share for the latest quarter. HNZ’s shares gained 0.29% to $46.38 in after-hours trading. PerkinElmer Inc (NYSE: PKI) has announced to sell its...
-
Luminex's New Cystic Fibrosis Test - Analyst Blog
Friday, August 27, 2010 - 12:54pm | 423Luminex Corporation (LMNX), a developer of biological testing technologies, has commenced the commercial launch of its new cystic fibrosis (a genetic disorder) diagnostic test dubbed “xTAG Cystic Fibrosis 60 Kit v2” following its recent approval by the U.S. Food and Drug Administration (FDA). The...
-
Top Cord Blood Stocks
Thursday, August 26, 2010 - 10:53am | 903The University of South Florida Department of Neurosurgery and Brain Repair just published the results of their research showing that after stroke-like damage, human umbilical cord blood cells protect astrocytes (animal cells) from cell death when deprived of oxygen. Cord blood is blood that comes...